BackCyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 Overview

Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 Total Revenue

Revenue analysis for CYCCP.

Quarterly Revenue

$778.00

As of Mar 2026

Annual Revenue (TTM)

$747778.00
↓ 2237.36% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin